Michael Murray

9PUBLICATIONS
3CO-AUTHORS
GlycoconjugatesMolecular targetsPharmacogenomicsMolecular medicineMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2026
Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation-Related Diseases.

|Jun 30, 2024
Carbon Chain Length in a Novel Anticancer Aryl-Urea Fatty Acid Modulates Mitochondrial Targeting, Reactive Oxygen Species Production and Cell Killing.

Yasmin A Elmaghrabi, Ariane Roseblade, Khalilur Rahman

|Mar 05, 2024
The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy.

Michael Murray

|Sep 21, 2023
Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.

Michael Murray

|Jul 30, 2022
The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells.

Stanton Tam, Yassir Al-Zubaidi, Md Khalilur Rahman

|Nov 28, 2019
Carbon Chain Length Modulates MDA-MB-231 Breast Cancer Cell Killing Mechanisms by Mitochondrially Targeted Aryl-Urea Fatty Acids.

Michael Murray, Ariane Roseblade, Yongjuan Chen

Pageof 2

Frequent Collaborators

1 joint publications

Ke Wang

1 joint publications

Ling Zhu

1 joint publications

Fanfan Zhou